The Problem of Comorbid Socially Significant Infections Under The Conditions of The COVID-19 Pandemic-Reference-Cited by-同舟云学术

The Problem of Comorbid Socially Significant Infections Under The Conditions of The COVID-19 Pandemic

Published:2022-11-16 Issue:7-8 Volume:67 Page:40-44
ISSN:0235-2990
Container-title:Antibiotics and Chemotherapy
language:
Short-container-title:A&Ch

Author:

KOLOMIETS V. M.¹,POLSHIKOVA N. A.¹,KOVALENKO A. L.²,PAVLENKO E. P.¹

Affiliation:

1. Kursk State Medical University of the Ministry of Health of the Russian Federation

2. Scientific Advisory Center of Toxicology named after S. N. Golikov

Publisher

Publishing House OKI

Subject

Infectious Diseases,Microbiology (medical),General Medicine,Microbiology

Reference15 articles.

1. Global tuberculosis report 2021. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.

2. Mishra A., George A.A., Sahu K.K., Lal A., Abraham G. Tuberculosis and COVID-19 сo-infection: An Updated Review. Acta Biomed. 2020 Nov 10; 92 (1): e2021025. doi:10.23750/abm.v92i1.10738.

3. Song W.M., Zhao G.Y., Zhang Q.Y., Liu S.Y., Zhu X.H., An Q.Q., Xu T.T., Li S.J., Liu J.Y., Tao N.N., Liu Y., Li Y.F., Li H.C. COVID-19 and Tuberculosis Coinfection: An Overview of Case Reports/Case Series and Meta-Analysis. Front Med (Lausanne). 2021 Aug 24; 8: 657006. doi:10.3389/fmed.2021.657006. eCollection 2021.

4. Wang Q., Guo S., Wei X., Dong Q., Xu N., Li H., Zhao J., Sun Q. Global prevalence, treatment and outcome of tuberculosis and COVID-19 coinfection: a systematic review and meta-analysis (from November 2019 to March 2021). BMJ Open. 2022. Jun 20; 12 (6): e059396. doi:10.1136/bmjopen-2021-059396.e059396.

5. Vliyanie koronavirusnoj infektsii COVID-19 na situatsijyu v Rossijskom zdravookhranenii. Analiticheskij doklad pod obshchej red. akademika RAN V. I. Starodubova. Moscow: 2020; 45. (in Russian)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antituberculars;Reactions Weekly;2023-04-15